348 related articles for article (PubMed ID: 34407152)
1. Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
Fauzi YR; Nakahata S; Chilmi S; Ichikawa T; Nueangphuet P; Yamaguchi R; Nakamura T; Shimoda K; Morishita K
PLoS One; 2021; 16(8):e0256320. PubMed ID: 34407152
[TBL] [Abstract][Full Text] [Related]
2. Degradation of p47 by autophagy contributes to CADM1 overexpression in ATLL cells through the activation of NF-κB.
Sarkar B; Nishikata I; Nakahata S; Ichikawa T; Shiraga T; Saha HR; Fujii M; Tanaka Y; Shimoda K; Morishita K
Sci Rep; 2019 Mar; 9(1):3491. PubMed ID: 30837480
[TBL] [Abstract][Full Text] [Related]
3. Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy.
Ishikawa C; Senba M; Mori N
Invest New Drugs; 2021 Apr; 39(2):317-329. PubMed ID: 32959166
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis.
Lin YC; Lin JF; Wen SI; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
Kaohsiung J Med Sci; 2017 May; 33(5):215-223. PubMed ID: 28433067
[TBL] [Abstract][Full Text] [Related]
5. Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2017 Aug; 51(2):633-643. PubMed ID: 28586006
[TBL] [Abstract][Full Text] [Related]
6. NF-κB Signaling Activation Induced by Chloroquine Requires Autophagosome, p62 Protein, and c-Jun N-terminal Kinase (JNK) Signaling and Promotes Tumor Cell Resistance.
Yang S; Qiang L; Sample A; Shah P; He YY
J Biol Chem; 2017 Feb; 292(8):3379-3388. PubMed ID: 28082672
[TBL] [Abstract][Full Text] [Related]
7. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
Watanabe M; Ohsugi T; Shoda M; Ishida T; Aizawa S; Maruyama-Nagai M; Utsunomiya A; Koga S; Yamada Y; Kamihira S; Okayama A; Kikuchi H; Uozumi K; Yamaguchi K; Higashihara M; Umezawa K; Watanabe T; Horie R
Blood; 2005 Oct; 106(7):2462-71. PubMed ID: 15956280
[TBL] [Abstract][Full Text] [Related]
8. NF-κB signaling mechanisms in HTLV-1-induced adult T-cell leukemia/lymphoma.
Harhaj EW; Giam CZ
FEBS J; 2018 Sep; 285(18):3324-3336. PubMed ID: 29722927
[TBL] [Abstract][Full Text] [Related]
9. Anti-adult T‑cell leukemia/lymphoma activity of cerdulatinib, a dual SYK/JAK kinase inhibitor.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2018 Oct; 53(4):1681-1690. PubMed ID: 30066853
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion.
Mauthe M; Orhon I; Rocchi C; Zhou X; Luhr M; Hijlkema KJ; Coppes RP; Engedal N; Mari M; Reggiori F
Autophagy; 2018; 14(8):1435-1455. PubMed ID: 29940786
[TBL] [Abstract][Full Text] [Related]
11. C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma.
Guimaraes-Correa AB; Crawford LB; Figueiredo CR; Gimenes KP; Pinto LA; Grassi MFR; Feuer G; Travassos LR; Caires ACF; Rodrigues EG; Marriott SJ
Viruses; 2011 Jul; 3(7):1041-1058. PubMed ID: 21994769
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
13. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine Autophagic Inhibition Rebalances Th17/Treg-Mediated Immunity and Ameliorates Systemic Lupus Erythematosus.
An N; Chen Y; Wang C; Yang C; Wu ZH; Xue J; Ye L; Wang S; Liu HF; Pan Q
Cell Physiol Biochem; 2017; 44(1):412-422. PubMed ID: 29141242
[TBL] [Abstract][Full Text] [Related]
15. The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases.
Martinez GP; Zabaleta ME; Di Giulio C; Charris JE; Mijares MR
Curr Pharm Des; 2020; 26(35):4467-4485. PubMed ID: 32634079
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.
Wang N; Han S; Liu R; Meng L; He H; Zhang Y; Wang C; Lv Y; Wang J; Li X; Ding Y; Fu J; Hou Y; Lu W; Ma W; Zhan Y; Dai B; Zhang J; Pan X; Hu S; Gao J; Jia Q; Zhang L; Ge S; Wang S; Liang P; Hu T; Lu J; Wang X; Zhou H; Ta W; Wang Y; Lu S; He L
Phytomedicine; 2020 Dec; 79():153333. PubMed ID: 32920291
[TBL] [Abstract][Full Text] [Related]
17. p53 dysfunction precedes the activation of nuclear factor-κB during disease progression in mice expressing Tax, a human T-cell leukemia virus type 1 oncoprotein.
Ohsugi T; Ishida T; Shimasaki T; Okada S; Umezawa K
Carcinogenesis; 2013 Sep; 34(9):2129-36. PubMed ID: 23633516
[TBL] [Abstract][Full Text] [Related]
18. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
[TBL] [Abstract][Full Text] [Related]
19. Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.
Rauch DA; Ratner L
Viruses; 2011 Jun; 3(6):886-900. PubMed ID: 21994759
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Eur J Pharmacol; 2020 Apr; 872():172953. PubMed ID: 31996318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]